Literature DB >> 6360771

Experimental galactosemia produces diabetic-like retinopathy.

R L Engerman, T S Kern.   

Abstract

Six normal dogs were made galactosemic by feeding a 30% D-galactose diet, and were followed up to 5 yr. For comparison, 10 normal dogs and 10 alloxan-diabetic dogs were concurrently fed the diet less the galactose supplement. Retinopathy occurred in each of four dogs glactosemic 3 or more yr, and was absent at lesser durations of galactosemia, and from normal dogs not given the galactose supplement. The retinopathy was marked by saccular capillary aneurysms, hemorrhages, nonperfused or acellular vessels, tortuous hypertrophic capillaries, loss of capillary pericytes, and other lesions typical of diabetic patients and alloxan-diabetic dogs. In galactose-fed dogs, blood galactose varied between 0 (fasted) and 250 mg/dl (postprandial), and glycosylated hemoglobin levels became supranormal. In contrast to diabetic dogs, blood levels of glucose, free fatty acids, and branched-chain amino acids were not elevated in the galactosemic dogs, and their serum insulin seemed normal. The results suggest that the level of blood hexose is itself an important determinant of retinopathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360771     DOI: 10.2337/diab.33.1.97

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  55 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  The polyol pathway in retinal microangiopathy.

Authors:  W G Robison; J H Kinoshita; P F Kador
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 3.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

4.  Hyperglycemia and the pathogenesis of diabetic retinopathy.

Authors:  G L King
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

Review 5.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

6.  Prevention of diabetes-induced albuminuria in transgenic rats overexpressing human aldose reductase.

Authors:  Daniel P K Ng; Charles L Hardy; Wendy C Burns; Evelyne E Muggli; Nicole Kerr; Jane McCausland; Daine Alcorn; Timothy E Adams; Jeffrey D Zajac; Richard G Larkins; Marjorie E Dunlop
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

7.  In Vitro Sugar Interference Testing With Amperometric Glucose Oxidase Sensors.

Authors:  Ryan Boehm; John Donovan; Disha Sheth; Andrew Durfor; Jason Roberts; Irada Isayeva
Journal:  J Diabetes Sci Technol       Date:  2018-08-03

8.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture.

Authors:  R M Knott; M Robertson; J V Forrester
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

10.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.